Author

Jie Yin

Leiden UniversityORCID 0009-0005-6327-4273Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Jie Yin1 paper · SeekGene BioSciences Co. Ltd., Beijing, China;

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Ewa B. Snaar-JagalskaiD· 1 shared Gabriel Forn‐CuníiD· 1 shared Gangyin ZhaoiD· 1 shared Lanpeng CheniD· 1 shared Leonardo Passarini· 1 shared Marvin ScheersiD· 1 shared Pier Pieterszoon LindenberghiD· 1 shared Quint C. van LooseniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ewa B. Snaar-JagalskaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer LettersPeer-reviewedFeb 7, 2024

Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer

Gangyin Zhao, Gabriel Forn‐Cuní, Marvin Scheers…·Ewa B. Snaar-Jagalska

This study shows that targeting both AMPK and mTOR can inhibit prostate cancer metastasis by blocking the metabolic switch required for tumor growth in new environments.

24 citations

humanexperimental assay

𝕏 PostBluesky